CAI Zhi-Li, HE Yi-Tao, FU Xue-Jun, ZOU Liang-Yu, LI Zhuo-Xing, ZHOU Zhi-Fan, CHEN Si-Yan, WANG Qian, GUO Yi. Clinical Analysis of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Different Causes[J]. Chinese Journal of Stroke, 2020, 15(05): 504-509.
[1] WANG W Z,JIANG B,SUN H X,et al. Prevalence,incidence,and mortality of stroke in China:resultsform a nationwide population-based survey of 480 687adults[J]. Circulation,2017,135(8):759-771.[2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682.[3] POWERS W J,RABINSTEIN A A,ACKERSONT,et a1. 2018 guidelines for the early management ofpatients with acute ischemic stroke:a guideline for healthcare professionals from the American HeartAssociation/American Stroke Association[J/OL].Stoke,2018,49(3):e46-e99[2019-12-03].https://doi.org/10.1161/STR.0000000000000158.[4] EMBERSON J,LESS K R,LYDEN P,et al. Effectof treatment delay,age,and stroke severity on theeffects of intravenous thrombolysis with alteplase foracute ischaemic stroke:a meta-analysis of individualpatient data from randomised trials[J]. Lancet,2014,384(9958):1929-1935.[5] GAO S,WANG Y J,XU A D,et al. Chineseischemic stroke subclassification[J]. Front Neurol,2011,2:6.[6] National Institute of Neurological Disordersand Stroke rt-PA Stroke Study Group. Tissueplasminogen activator for acute ischemic stroke[J].N Engl J Med,1995,333(24):1581-1587.[7] HACKE W,KASTE M,BLUHMKI E,et al.Thrombolysis with alteplase 3 to 4.5 hours afteracute ischemic stroke[J]. N Engl J Med,2008,359(13):1317-1329.[8] 蒋王乐,徐俊,徐耀,等. 穿支动脉疾病患者病情进展相关因素的分析[J]. 中华老年心脑血管病杂志,2017,19(9):961-964.[9] PETTY G W,BROWN R D Jr,WHISNANT JP,et al. Ischemic stroke subtypes:a populationbasedstudy of survival,recurrence,and functionaloutcome[J]. Neurology,2000,31(5):1062-1068.[10] ARBOIX A,MASSONS J,GARCÍA-EROLES L,et al. Trends in clinical features and early outcomein patients with acute cardioembolic stroke subtypeover a 19-year period[J]. Neurol India,2012,60(3):288-293.[11] ANTICOLI S,BRAVI M C,PERILLO G,et al.Effect of cardioembolic etiology on intravenousthrombolysis efficacy for acute ischemic stroke[J].Curr Neurovasc Res,2016,13(3):193-198.[12] PAN Y T,LEE J D,LIN Y H,et al. Comparisonsof outcomes in stroke subtypes after intravenousthrombolysis[J]. Springerplus,2016,5:47.[13] GRIEBE M,FISCHER E,KABLAU M,et al.Thrombolysis in patients with lacunar stroke is safe:an observational study[J]. J Neurol,2014,261(2):405-411.[14] WANG X G,ZHANG L Q,LIAO X L,et al.Unfavorable outcome of thrombolysis in Chinesepatients with cardioembolic stroke:a prospective cohort study[J]. CNS Neurosci Ther,2015,21(8):657-661.[15] KIMURA K,IGUCHI Y,YAMASHITA S,et al.Atrial fibrillation as an independent predictor for noearly recanalization after IV-t-PA in acute ischemicstroke[J]. J Neurol Sci,2008,267(1-2):57-61.[16] VACLAVIK D,VILIONSKIS A,JATUZIS D,etal. Clinical outcome of cardioembolic stroke treatedby intravenous thrombolysis[J]. Acta Neurol Scand,2018,137(3):347-355.[17] FORLIVESI S,BOVI P,TOMELLERI G,etal. Stroke etiologic subtype may influence therate of,hyperdense middle cerebral artery signdisappearance after intravenous thrombolysis[J]. JThromb Thrombolysis,2017,43(1):86-90.[18] FRANK B,FULTON R,WEIMAR C,et al. Impactof atrial fibrillation on outcome in thrombolyzedpatients with stroke:evidence from the VirtualInternational Stroke Trials Archive(VISTA)[J].Stroke,2012,43(7):1872-1877.[19] MOLINA C A,MONTANER J,ARENILLAS JF,et al. Differential pattern of tissue plasminogenactivator-induced proximal middle cerebral arteryrecanalization among stroke subtypes[J]. Stroke,2004,35(2):486-490.[20] ALBERS G W,THIJS V N,WECHSLE L,et al.Magnetic resonance imaging profiles predict clinicalresponse to early reperfusion:the diffusion andperfusion imaging evaluation for understandingstroke evolution(DEFUSE)study[J]. Ann Neurol,2006,60(5):508-517.[21] MOLINA C A,ALVAREZ-SABIN J. Recanalizationand reperfusion therapies for acute ischemicstroke[J]. Cerebrovasc Dis,2009,27(Suppl 1):162-167.[22] HEINSIUS T,BOGOUSSLAVSKY J,VANMELLE G. Large infarcts in the middle cerebralartery territory. Etiology and outcome patterns[J].Neurology,1998,50(2):341-350.[23] ZHANG J B,DING Z Y,YANG Y,et al.Thrombolysis with alteplase for acute ischemicstroke patients with atrial fibrillation[J]. Neurol Res,2010,32(4):353-358.[24] 刘艳艳,张敏,恽文伟,等. 中重度脑白质疏松对急性脑梗死静脉溶栓患者出血转化及预后的影响[J].中华神经科杂志,2017,50(12):885-891.
HUO Xiaochuan, LI Xiaoqing, MIAO Zhongrong, Expert Committee for Neurointervention Quality Control of National Center for Healthcare Quality Management in Neurological Diseases, Endovascular Treatment Working Committee of National Action for Quality Improvement of Acute Cerebral Infarction Reperfusion Therapy.
A Survey of Current Practice in Acute Ischemic Stroke Endovascular Treatment in China in 2020
[J]. Chinese Journal of Stroke, 2022, 17(01): 56-65.